Interviews
In Conversation : Jean-Marie Aulnette, Vice President of EMEA sales, TraceLink on Serialization And Traceability
What do you think is the biggest hurdle when it comes to serialization in the industry?The huge volume of data that will be generated and shared across the industry presents the greatest challenge. Serialization creates the need for a...
Interviews
Anand Modi, VP Sales India at Tracelink, on Generic Companies In the Pharma Sector
How are Indian generics companies fairing in the competitive race to serialize and ship medicines to the US?Though the serialization deadline has passed for the Drug Supply Chain Security Act (DSCSA)in the US, companies across the globe are still...
Interviews
Idifarma with its new automated capsule
1. What does this approval mean to Idifarma?It’s a great opportunity for growth, boosting our GMP capabilities with capsule filling in addition to immediate and modified release tablets. It is also a significant milestone in our journey so far,...
Interviews
Innovative creative solutions to integrate development cycles
1. Will this merger change any of your organizational structure and framework?The partnership is not a merger, it is a collaboration between Recipharm and the Clinical Trial Consultants (CTC) to allow both companies to offer a complete service from...
Interviews
Yesterday, Today, Tomorrow ChargePoint Technology
What does this certification mean to you?Achieving the highest level of certification in Atmosphere Explosive (ATEX) and International Electro Commission (IEC) Explosive (Ex) equipment,combined with recent investment in our Liverpool facility, forms an important part of our strategy to...
Interviews
A New Approach To Pharmacovigilance
1.Quanticate has just completed an investment initiative to upgrade its pharmacovigilance safety data base,how will the new system simplify event reporting in the EU and enhance data availability to stake holders?
The upgrade of our safety database ties in with...
Interviews
Clinical Trial Disclosure Maturity Assessment Process Disclosed By TrialScope
1. In an environment where trial data is made available through peer reviewed articles how effective is clinical trial disclosure maturity assessment with increased risk, complexity and costs to assess global disclosure processes? The Clinical Trial...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
